
Metotip 25mg Tablet ER
Marketer
Zodley Pharmaceuticals Pvt Ltd
Salt Composition
Metoprolol Succinate (25mg)
Overview Metotip 25mg Tablet ER
Cardiol 25mg Extended-Release Tablets are a beta-blocker medication indicated for managing hypertension, angina pectoris, and cardiac arrhythmias. This medication also aids in migraine prophylaxis and reducing the risk of future myocardial infarction and cerebrovascular accidents. Cardiol 25mg ER may be administered as monotherapy or in conjunction with other drugs; dosage and frequency are individualized based on the specific condition and its severity. It can be taken with or without food, but consistent daily timing is crucial for optimal efficacy. Full therapeutic benefits may not be apparent for several weeks, and continuous use may be necessary long-term. Discontinuation can exacerbate underlying conditions. Common, generally mild and transient, adverse effects include fatigue, cephalgia, depressive symptoms, diarrhea, dermatological reactions, bradycardia, dizziness, and nausea. Some patients may experience dyspnea or hypotension. Gradual dose escalation is typically employed to minimize adverse reactions. Report persistent or bothersome side effects to your physician. Prior to initiating therapy, disclose any hepatic impairment. This medication is contraindicated in patients with bradycardia, severe peripheral vascular disease, decompensated heart failure, or hypotension. Pregnant or lactating individuals should seek medical counsel before use. A physician's evaluation is essential to determine suitability. Regular blood pressure monitoring is vital to assess treatment effectiveness. Alcohol consumption should be limited due to potential exacerbation of adverse effects.
Primary Ingredients of Metotip 25mg Tablet ER
There is no text provided to rephrase.
Uses of Metotip 25mg Tablet ER
Management of angina pectoris | Cardiac arrhythmia management | Myocardial infarction prophylaxis | Hypertension therapy | Migraine prevention
Major Benefits of Metotip 25mg Tablet ER:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the 25mg extended-release Metotip tablet whole; avoid crushing, chewing, or breaking it. This medication can be taken with or without food, but consistent timing is recommended. Minimize consumption of high-fat foods, including olive oil, nuts (especially Brazil nuts), dark chocolate, butter, and fatty meats, while taking Metotip 25mg Tablet ER.
Common Side effects of Metotip 25mg Tablet ER:
- Tiredness
- Dizziness
- Depression
- Breathlessness
- Headache
- Slow heart rate
- Nausea
- Rash
- Diarrhea
- Hypotension (low blood pressure)
How to use Metotip 25mg Tablet ER:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Metotip 25mg Extended-Release tablet whole; do not crush, chew, or break it. This medication can be taken with or without food, but consistent timing is recommended. Minimize consumption of Metotip 25mg Tablet ER with meals high in fat, including those containing olive oil, nuts and seeds (like Brazil nuts), dark chocolate, butter, and fatty meats.
How Metotip 25mg Tablet ER works:
Extended-release Metotip 25mg tablets are a cardioselective beta-adrenergic blocking agent. They reduce heart rate and enhance the heart's pumping efficiency, providing prolonged therapeutic benefit.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Metotip 25mg Extended-Release Tablets is contraindicated.
PregnancyCONSULT YOUR DOCTOR
Extended-release Metotip 25mg tablets might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescription. Physician consultation is advised.
Breast feedingSAFE IF PRESCRIBED
Extended-release Metotip 25mg tablets are likely safe for breastfeeding mothers. Available evidence from human studies indicates minimal risk to the infant.
DrivingUNSAFE
Extended-release Metotip 25mg tablets can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
Extended-release metotip 25mg tablets are considered safe for patients with renal impairment; no dosage modification is necessary.
LiverCAUTION
Extended-release Metotip 25mg tablets require careful administration in individuals with hepatic impairment. Dosage modification of Metotip 25mg extended-release tablets may be necessary. Physician consultation is advised.
What if you forget to take Metotip 25mg Tablet ER :
Should you forget a Metotip 25mg Extended-Release Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Metotip 25mg Tablet ER
| Label | Value |
|---|---|
| Chemical Classification | Alcohols and Phenols |
| Developing Habits | No. |
| Treatment Category | Heart |
